Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a phone app beat fatty liver? new trial tests digital coaching

NCT ID NCT07007741

First seen Apr 28, 2026

Summary

This trial tests whether a smartphone app and remote diet/exercise coaching can help people with non-alcoholic fatty liver disease lose weight and reduce liver fat. 120 participants will either get standard lifestyle advice or use the app with daily meal tracking, weekly recipe adjustments, and one-on-one Q&A with a dietitian. The study is active but not recruiting, and results could show if digital tools can improve liver health at scale.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NONALCOHOLIC FATTY LIVER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • XinHua Hospital Affiliated To Shanghai Jiao Tong University School of Medicine

    Shanghai, Shanghai Municipality, 200082, China

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Fatty Liver Data Analysis and Management Software (smartphone app with remote diet/exercise coaching)

What this could lead to

If it works, this could provide an effective, scalable way for doctors to help people with fatty liver lose weight and reduce liver fat through remote lifestyle coaching.

What could go wrong

This is a small, early-stage trial (120 people) testing a software tool, not a drug. The results may not apply to everyone, and the app's success depends on daily user engagement.

Conditions

The condition(s) this trial relates to.

metabolic dysfunction-associated steatohepatitis metabolic dysfunction-associated steatotic liver disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.